ACTRN12618001630202已完成未知
Efficacy andsafetyartemether-lumefantrineand dihydroartemisinin-piperaquine for thetreatment of uncomplicated Plasmodium falciparum malaria and chloroquine for P. vivax in Buthidaung, Rakhine State
Ministry of Health and Sports0 个研究点目标入组 210 人开始时间: 2018年10月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Therapeutic efficacy studies of artemisinin combination treatment (ACT) in Myanmar (2019)MalariaACTRN12619001624178Ministry of Health and Sports150
已完成
不适用
Safety and efficacy of artemether-lumefantrine therapy for Intermittent Preventive Treatment in pregnancy in UgandaMalariaISRCTN12394097ICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)1,664
已完成
4 期
Efficacy and safety of Artemether-Lumefantrine and dihydroartimisininne-pipraquine for the treatment of uncomplicated Plasmodium falciparum malaria in different sentinel site in SudaInfection - Studies of infection and infectious agentsMalariaACTRN12618001800213Ministry of Health362
招募中
4 期
Therapeutic Efficacy Studies (TES) of antimalarialMalariaPACTR201811640750761nited States Agency for International Development1,000
已完成
4 期
Efficacy and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum in Dolisie, Republic of CongoInfection - Studies of infection and infectious agentsMalariaACTRN12616001422415Ministry of Health and Population176